@article{4686d2add17940258d97ed4e63935cc3,
title = "Phosphoproteomics Identifies CK2 as a Negative Regulator of Beige Adipocyte Thermogenesis and Energy Expenditure",
abstract = "Catecholamines promote lipolysis both in brown and white adipocytes, whereas the same stimuli preferentially activate thermogenesis in brown adipocytes. Molecular mechanisms for the adipose-selective activation of thermogenesis remain poorly understood. Here, we employed quantitative phosphoproteomics to map global and temporal phosphorylation profiles in brown, beige, and white adipocytes under β3-adrenenoceptor activation and identified kinases responsible for the adipose-selective phosphorylation profiles. We found that casein kinase2 (CK2) activity is preferentially higher in white adipocytes than brown/beige adipocytes. Genetic or pharmacological blockade of CK2 in white adipocytes activates the thermogenic program in response to cAMP stimuli. Such activation is largely through reduced CK2-mediated phosphorylation of class I HDACs. Notably, inhibition of CK2 promotes beige adipocyte biogenesis and leads to an increase in whole-body energy expenditure and ameliorates diet-induced obesity and insulin resistance. These results indicate that CK2 is a plausible target to rewire the β3-adrenenoceptor signaling cascade that promotes thermogenesis in adipocytes.",
author = "Kosaku Shinoda and Kana Ohyama and Yutaka Hasegawa and Chang, {Hsin Yi} and Mayu Ogura and Ayaka Sato and Haemin Hong and Takashi Hosono and Sharp, {Louis Z.} and Scheel, {David W.} and Mark Graham and Yasushi Ishihama and Shingo Kajimura",
note = "Funding Information: We are grateful to Dr. Patrick Seale for providing the cell line, and to Dr. Yuriy Kirichok, Dr. Christophe Paillart, Kathleen Jay, Dylan Lowe, Miranda Broz, and Svetlana Keylin for their kind support. This work was supported by grants from the NIH ( DK087853 and DK97441 ) to S.K. We also acknowledge supports from the DERC center grant ( DK63720 ), UCSF Liver Center ( P30 DK026743 ), the Pew Charitable Trust , and PRESTO from Japan Science and Technology Agency (also to S.K.). K.S. is supported by a fellowship from The Larry L. Hillblom Foundation . Y.H. is supported by Manpei Suzuki Diabetes Foundation . M.G. is an employee and stock holder of Isis Pharmaceuticals. H.C. is supported by a fellowship from the Japan Society for the Promotion of Science . Publisher Copyright: {\textcopyright} 2015 Elsevier Inc.",
year = "2015",
month = jan,
day = "1",
doi = "10.1016/j.cmet.2015.09.029",
language = "English",
volume = "22",
pages = "997--1008",
journal = "Cell Metabolism",
issn = "1550-4131",
publisher = "Cell Press",
number = "6",
}